Fig. 1From: Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcomeMedian overall survival times with brain metastases under therapy. There were no significant differences in patients with BM treated with radiation, surgery plus radiation or observation (8 vs. 7 vs. 18 months; P = 0.72) (a). When dividing these patients in an observation and therapeutic arm similar results were obtained (18 vs. 8 months; P = 0.46) (b)Back to article page